Abstract
This Frost & Sullivan research service titled Key Trends in Patient Monitoring
across Europe provides an insight into the pharmaceutical and biotech sectors
and their strategies for new and innovative methods of drug delivery. In
addition, the business strategy trends currently important in drug delivery
relative to business development, licensing and lifecycle management are
discussed. In this research service, Frost & Sullivan' s expert analysts
examine the following market segments: neurophysiologic monitoring, ECG
monitoring, foetal monitoring, central station monitoring, multiparameter
monitoring and respiratory monitoring.
This analysis is available through our Patient Monitoring Growth Partnership
Service programme. With this programme, clients receive industry-leading
market research such as this, along with technical and econometric data and
many interactive features including Analyst Inquiry Time and Client Councils.